topic-orcrp006545 GlaxoSmithKline PLC news, photos and video - CTnow
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 85-96 of 199
» View courant.com items only
    Sep 13, 2011 |Story| Reuters
  1. IUDs almost halve risk of cervical cancer: study

    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of an international study.
    Reuters
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...

    Tags: Diseases and Illnesses, Viral Diseases and Infections, Merck & Company Incorporated, Medical Research, Cancer

  2. Sep 25, 2011 |Story| Reuters
  3. Cancer study boosts hopes for Roche's armed antibody

    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday.
    Reuters
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...

    Tags: Diseases and Illnesses, University of California, Los Angeles, Stockholm (Sweden), Herceptin (drug), Breast Cancer

  4. Sep 27, 2011 |Story| Chicago Tribune
  5. Drug companies pay $25 million to Illinois doctors

    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...

    Tags: Birmingham , Chicago, Gainesville, Marketing, Companies and Corporations

  6. Sep 20, 2011 |Story| Reuters
  7. Tailored breast cancer drugs in focus at cancer meet

    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis.
    Reuters
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...

    Tags: Diseases and Illnesses, Litigation, Food and Drug Administration, Stockholm (Sweden), Herceptin (drug)

  8. Nov 2, 2011 |Story| Reuters
  9. Study: At-home cervical cancer test could save thousands

    A do-it-yourself test for cervical cancer could help prevent thousands of cases of the disease in women who don't have easy or regular access to smear tests, scientists said Wednesday. The DIY test, which detects the human papillomavirus (HPV)...

    Tags: Medical Procedures and Tests, Diseases and Illnesses, Mexico, Viral Diseases and Infections, Merck & Company Incorporated

  10. Nov 24, 2011 |Story| Reuters
  11. UK switches to Merck's Gardasil for HPV vaccination

    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil.
    Reuters
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...

    Tags: HPV Vaccine, Diseases and Illnesses, Viral Diseases and Infections, Merck & Company Incorporated, Drugs and Medicines

  12. Jun 20, 2011 |Story| Reuters
  13. |Story
  14. Jun 16, 2011 |Story| Coastline Pilot
  15. Mailbag: Should they sell seashells at store?

    Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2). Yes, I know, they are big sellers, and make money for the merchants....

    Tags: Crime, Law and Justice, Health and Safety at Work, Fraud, Epidemics and Plagues, Chemical Industry

  16. Jun 13, 2011 |Story| Baltimore Sun
  17. Wealthy nations must follow through on disease fight

    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly killing children on the reservation at a rate seven times the national average.
    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...

    Tags: Health and Safety at School, Economy, Business and Finance, Diseases and Illnesses, Maryland, Merck & Company Incorporated

  18. Sep 19, 2011 | Los Angeles Times
  19. Malaria vaccine: The fiction and the reality

    Opinion L.A.
    Ann Patchett has earned all sorts of praise for her bestseller, "State of Wonder," but as engaging as the story is, the book's science concerning a malaria vaccine left something -- well, several things -- to be desired. The reality is that with all the...
  20. May 25, 2011 |Story| Los Angeles Times
  21. Oct 28, 2010 |Story| Chicago Tribune
  22. Doctor-drug company database adds to confusion for consumers

    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues. He found several doctors who had potentially compromising...

    Tags: Merck & Company Incorporated, Medical Research, Chemical Industry, Healthcare Provider, Lilly Eli & Co

< Previous1 2 3 4 5 6 7  8  9 10 11-17Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
CEO of GlaxoSmithKline, Andrew Witty, poses for photogr...
(July 2, 2012)
CEO Andrew Witty